SMTL ID : 6tnr.1

PI3K delta in complex with N[5(7{2[4(2hydroxypropan2yl)piperidin1 yl]ethoxy}1,3dihydro2benzofuran5yl)2 methoxypyridin3yl]methanesulfonamide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x NQ2: ~{N}-[2-methoxy-5-[7-[2-[4-(2-oxidanylpropan-2-yl)piperidin-1-yl]ethoxy]-1,3-dihydro-2-benzofuran-5-yl]pyridin-3-yl]methanesulfonamide(Non-covalent)

NQ2.1: 19 residues within 4Å: Chain A: T.646, F.647, M.648, S.650, P.654, W.656, I.673, K.675, L.680, D.683, Y.709, I.721, E.722, V.723, V.724, T.729, M.796, I.806, D.807 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:T.646, A:W.656, A:W.656, A:I.673, A:I.721, A:I.806, A:I.806 Hydrogen bonds: A:S.650, A:K.675, A:V.724, A:D.807, A:D.807 Water bridges: A:K.675, A:K.675, A:K.675, A:Y.709

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Henley, Z.A. et al., Optimization of Orally Bioavailable PI3K delta Inhibitors and Identification of Vps34 as a Key Selectivity Target. J.Med.Chem. (2020)

Release Date

2020-01-01

Peptides

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform

Related Entries With Identical Sequence